A Prospective, Single-arm Phase II Clinical Trial of Tislelizumab Combined With Platinum Doublet Neoadjuvant Therapy to Improve Mandibular Preservation in Resectable Locally Advanced Oral Squamous Cell Carcinoma.
Clinical trial NCT06130007 · UNKNOWN
Trial details
- NCT number
- NCT06130007
- Sponsor
- Xuekui Liu
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-25
- Primary completion
- 2024-09-25
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.